50.80 USD
↗ 3.30 (6.95%)AT CLOSE (11:59 AM EDT)
CareDx, Inc.
CDNANASDAQ • USD
51.28
↗ 0.48 (0.94%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
51.28
↗ 0.48 (0.94%)
Market: CLOSED
CareDx, Inc. (CDNA) is currently trading at $50.82. The stock presents a bullish profile across the board: both technical indicators and our fundamental models signal a "Buy" and "Buy" respectively. Notable factors include a robust Altman Z-Score, exceptional Return on Equity (26.1%), a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place CDNA at a fair price relative to peers.
Technical & fundamental data as of Aug 25, 2026.
Open?$48.13
High?$51.13
Low?$47.23
Prev. Close?$47.50
Volume?1.8M
Avg. Volume?1.2M
VWAP?$49.75
Rel. Volume?1.44x
Bid / Ask
Bid?$43.87 × 100
Ask?$58.37 × 100
Spread?$14.50
Midpoint?$51.12
Valuation & Ratios
Market Cap?2.5B
Shares Out?51.7M
Float?50.2M
Float %?97.0%
P/E Ratio?22.14
P/B Ratio?5.77
EPS?$2.15
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Themes
Employees
765
Market Cap
2.5B
Industry
SERVICES-MEDICAL LABORATORIES
Website
Listed
2014-07-17
Address
8000 MARINA BLVD
BRISBANE, CA 94005
Phone: 415-287-2300
BRISBANE, CA 94005
Phone: 415-287-2300
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?100
Momentum?90
Short Sent.?45
Piotroski F-Score?6/9Mixed
Altman Z-Score?25.00Safe
Confidence?65%Moderate
Short InterestHigh
Short % of Float?11.54%High
Short Interest?5.8M
Days to Cover?5.0
Free Float50.2M
Avg Daily Volume1.2M
Settlement Date2026-08-14
Financial Health
Current Ratio?4.58Strong
Quick Ratio?4.51Strong
Cash Ratio?3.99Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score61/100
P/E?22.1FAIR▾
Peers100
S&P57
P/B?5.77FAIR▾
Peers100
S&P32
P/S?5.36FAIR▾
Peers100
S&P26
P/FCF?29.0FAIR▾
Peers100
S&P31
EV/EBITDA?204.8HIGH▾
Peers100
S&P3
EV/Sales?4.55FAIR▾
Peers100
S&P40
Returns & Efficiency
ROE?26.1%STRONG▾
Peers50
S&P75
ROA?20.8%STRONG▾
Peers50
S&P97
Cash Flow & Enterprise
FCF?$84.7M
Enterprise Value?$2.1B
Fundamentals ratios updated end of day